Dev IT's Stock Gains Today After Company Gets New Order of Rs 4.4 Crore

Ahmedabad, Jul 2 (12:51 IST) – Shares of Dev Information Technology Ltd (NSE: DEVIT) rose 2.15% to ₹122.66 as of 1:10 p.m., on Wednesday, after the company announced securing IT contracts worth ₹4.4 crore from Alivus Lifesciences, a pharma-sector player. The scrip touched a high of ₹125.90, registering its highest level in over two months, and remains up 30% from its 52-week low of ₹94.43 hit on May 9, 2025.

Stock Performance Snapshot

Deal Breakdown: Strategic Tech Partnership

DEV IT’s new contracts with Alivus Lifesciences encompass two key components:

This strategic partnership highlights DEV IT’s capabilities in system integration and advisory services, particularly in facilitating complex licensing processes for Microsoft solutions. The direct order for enterprise software across various platforms (Microsoft, Zoho, Adobe, and TeamViewer) further solidifies DEV IT’s role as a comprehensive IT solutions provider.

Chairman’s Commentary

Mr. Pranav Pandya, Founder & Chairman, remarked:

“This milestone reflects not just a business win, but the trust our clients place in our team’s ability to solve real-world challenges with the right technology… We’re also seeing meaningful traction in the government sector.”

He also acknowledged the team’s execution, crediting key members for the successful closure of the deal.

Financial Snapshot (FY25 Consolidated)

Market and Valuation Metrics

This order win is expected to strengthen DEV IT’s presence in high-growth verticals such as pharmaceuticals and public sector digital transformation. The company continues to leverage its proprietary platforms like Talligence (analytics) and ByteSigner (digital signing) to enhance its enterprise integration capabilities.

What’s Next For Dev IT?

Dev IT’s latest order win from Alivus Lifesciences strengthens its position in the pharma-tech segment, showing it can deliver enterprise-grade software solutions beyond its government contracts. With growing traction in private sector verticals, the company is likely to build on this momentum to chase larger deals. Additionally, its proprietary tools like Talligence and ByteSigner could open up more niche revenue streams in analytics and digital trust solutions.

Looking ahead, investors will be watching for more order inflows, especially in the healthcare and public sector tech transformation space. Continued margin stability and execution on these contracts could support the stock’s medium-term upside.

About Dev IT

Dev Information Technology Limited (DEV IT) is a listed global IT services provider (NSE & BSE) offering digital transformation, cloud, and enterprise IT solutions. Founded in 1997 and headquartered in Ahmedabad, DEV IT also maintains a presence in Canada and holds certifications including ISO 20000, ISO 27001, ISO 9001, and CMMI Level 3.

REF: https://nsearchives.nseindia.com/corporate/DEVIT_02072025124845_Intimation.pdf

Disclaimer:  At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations